VTGN earnings
Vistagen Therapeutics (VTGN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- VTGN reports next on Feb 11, 2027, with EPS of -0.32 expected.
- VTGN beat EPS estimates in 7 of its last 10 reports.
VTGN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2027 | Nov 13, 2026 | -0.24 | – | – | $138.00K |
| Q1 2027 | Aug 14, 2026 | -0.30 | – | – | $1.48M |
| Q4 2026 | Jun 15, 2026 | -0.37 | -0.42 | 11.90% | $464.00K |
| Q3 2026 | Feb 12, 2026 | -0.45 | -0.51 | 11.76% | $303.00K |
| Q2 2026 | Nov 13, 2025 | -0.54 | -0.51 | -5.88% | $258.00K |
| Q1 2026 | Aug 7, 2025 | -0.47 | -0.47 | 0.00% | $244.00K |
| Q4 2025 | Jun 17, 2025 | -0.43 | – | – | -$15.00K |
| Q3 2025 | Feb 13, 2025 | -0.46 | -0.48 | 4.17% | $234.00K |
| Q2 2025 | Nov 7, 2024 | -0.42 | -0.40 | -5.00% | $183.00K |
| Q1 2025 | Aug 13, 2024 | -0.35 | – | – | $84.00K |
| Q4 2024 | Jun 11, 2024 | -0.25 | -0.34 | 26.47% | $198.00K |
| Q3 2024 | Feb 13, 2024 | -0.22 | – | – | $411.00K |
| Q2 2024 | Nov 9, 2023 | -0.66 | -0.68 | 2.94% | $278.00K |
| Q1 2024 | Aug 10, 2023 | -0.94 | -0.86 | -9.30% | $177.00K |
| Q3 2023 | Feb 7, 2023 | -1.50 | -1.80 | 16.67% | $179.60K |
| Q2 2023 | Nov 10, 2022 | -2.40 | – | – | -$892.50K |